Skip to Main Content

Advertisement

Skip Nav Destination

Robert Kreitman: Delayed Versus Concurrent Rituximab in Hairy Cell Leukemia

December 30, 2021

Robert Kreitman, MD, shares results from a new study suggesting patients with hairy cell leukemia should receive rituximab concurrently with frontline cladribine.

Advertisement

Connect with us:

CURRENT ISSUE
September 2022

Advertisement

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement